Pregabalin Capsule
Product Images NDC 71335-2339

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71335-2339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352339)

FDA Label Image

Figure 1 (Pregabalin Fig01)

FDA Label Image

Figure 2 (Pregabalin Fig02)

FDA Label Image

Figure 3 (Pregabalin Fig03)

FDA Label Image

Figure 4 (Pregabalin Fig04)

FDA Label Image

Figure 5 (Pregabalin Fig05)

FDA Label Image

Figure 6 (Pregabalin Fig06)

FDA Label Image

Figure 7 (Pregabalin Fig07)

FDA Label Image

Figure 9 (Pregabalin Fig08)

FDA Label Image

Figure 10 (Pregabalin Fig09)

Figure 10 (Pregabalin Fig09)
Estimated % Subjects without LTR: 100%, 0%, 80%, 70%, 60%, 50%, a0%, 30%, 20%, 10%, 0%. The text appears to be displaying data related to the percentage of subjects without LTR (Long-Term Remission) in different groups. The groups listed are "Progabain" and "Placebo". There is also a timeline represented in days (from 20 to 180).*
FDA Label Image

Figure 11 (Pregabalin Fig10)

FDA Label Image

Figure 12 (Pregabalin Fig11)

Figure 12 (Pregabalin Fig11)
This text provides information about the percent of subjects improved over the course of a study. It shows measurements at various time points, such as "Week 16 BOCF" and includes data for both the drug "Pregabalin" and a placebo.*
FDA Label Image

Figure 13 (Pregabalin Fig13)

Figure 13 (Pregabalin Fig13)
Based on the provided text, it appears to be a report or data related to a "Responder Rate." The responder rate is represented as a percentage and it includes values such as 60%, 50%, 40.6%, 29.1%, and 22.6%. Additionally, there is a reference to a "Placebo" with dosage information mentioned as "2.5 mglkglday" and "10 mg/kglday." The last line in the text shows the figures "93 103 9%," which might be associated with the responder rate or some form of comparison.*
FDA Label Image

Cockcroft And Gault Equation (Pregabalin Formula)

Cockcroft And Gault Equation (Pregabalin Formula)
This text appears to be a mathematical equation for calculating a value called CLCT. The equation involves the variables of age in years, weight in kg, serum creatinine level in mg/dL, and a constant of 0.85 for female patients. However, the specific purpose or context of the CLCT calculation is not provided in the given text.*
FDA Label Image

Chemical Structure (Pregabalin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.